pragma.vision Technology observatory & strategic foresight

Verification register Bio, Health & Neuro

Readiness verdict

Neuralink PRIME / N1 Gen-2

A dated reading of what is claimed, reported, and independently verified in the current evidence.

As of
2026-08-20
Revision
1
Method
v1.3.0

Current reading

Readiness band and full integer triple

AI-assisted assembly · derived results

Readiness band

Emerging

Primary summary from verified readiness

Confidence
82% · stale
Computed at
2026-08-20T10:51:39.435022+00:00
Claimed
45

Public ambition and stated capability

Reported
32

Observed practitioner reporting

Verified
21

Independently supported evidence

Gap
+24

Claimed leads verified

Evidence strength Strong

Decision

What the current evidence supports

Human editorial judgment · 2026-08-20

Track; not yet

Why
Genuine clinical milestones and very high coverage, but it remains an investigational early-feasibility BCI whose headline reliability was compromised by thread retraction and rescued only in software; maturity is exploratory, not productized.
Next
Monitor peer-reviewed Gen-2 longevity data (thread retention, multi-year signal stability) before treating as deployable; do not cite Neuralink throughput claims without the thread-retraction caveat

Constraints

Blockers

No named blocker is present in the current public projection.

Evidence summary

Derived counts

AI-assisted assembly

Total
14
Tier 1
6
Tier 2
6
Tier 3
2
Supports
2
Contradicts
4
Context
8
Latest observed
2026-05-20

Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.

Publication record

Revisions

Initial public reading

  1. 2026-07-19 Reading moved from emerging to emerging.

Your opinion

Tell us anything.

What works, what doesn't, what's missing — especially about our watches, lenses, and the register itself. Anonymous is fine; leave an email if you'd like a reply.